Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: what's new 12 months later?
Description
CONCLUSIONS: Disruption of routine healthcare services because of the pandemic translated to reduced 1 year overall and disease-free survival among patients affected by HCC, in the metropolitan area of Paris, France.
